V. Malerczyk
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
- Pharmacology 26
- Antibiotics Pharmacokinetics and Efficacy 23
- Pharmacogenetics and Drug Metabolism 9
- Drug-Induced Adverse Reactions 4
-
- Antibiotic Resistance in Bacteria 9
- Co-authors
- A. Korn (7 shared papers)M. Verho (11 shared papers)Karl‐Heinz Lehr (4 shared papers)M. Badian (6 shared papers)Bernd Rosenkranz (5 shared papers)W Waldhäusl (3 shared papers)Paul H. Heintzen (5 shared papers)Claudia Lange (1 shared paper)
- Journals
- Infection (5 papers)European Journal of Clinical Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Chemotherapy (2 papers)Current Medical Research and Opinion (2 papers)
- Partner nations
- GermanyBelgiumSouth Africa
In The Last Decade
V. Malerczyk
45 papers receiving 536 citations
Peers
Comparison fields: 5 of 89
- Molecular Medicine 96
- Pharmacology 258
- Pharmacology 64
- Clinical Biochemistry 47
- Endocrinology, Diabetes and Metabolism 98
Countries citing papers authored by V. Malerczyk
This map shows the geographic impact of V. Malerczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Malerczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Malerczyk more than expected).
Fields of papers citing papers by V. Malerczyk
This network shows the impact of papers produced by V. Malerczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Malerczyk. The network helps show where V. Malerczyk may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Malerczyk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 76 | |
| 2 | 1994 | 43 | |
| 3 | 1994 | 37 | |
| 4 | 1971 | 33 | |
| 5 | 1975 | 33 | |
| 6 | 1972 | 32 | |
| 7 | 1986 | 26 | |
| 8 | 1973 | 22 | |
| 9 | 1987 | 22 | |
| 10 | 1991 | 21 | |
| 11 | 1996 | 21 | |
| 12 | 1987 | 20 | |
| 13 | 1987 | 20 | |
| 14 | 1978 | 18 | |
| 15 | 1983 | 18 | |
| 16 | 1985 | 18 | |
| 17 | Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration. | 1987 | 15 |
| 18 | 1972 | 14 | |
| 19 | 1987 | 12 | |
| 20 | 1974 | 11 |
About V. Malerczyk
V. Malerczyk is a scholar working on Pharmacology, Pharmacology, Molecular Medicine, Pediatrics, Perinatology and Child Health and Oncology, having authored 47 papers that have together received 639 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Antibiotic Resistance in Bacteria (9 papers), Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (8 papers), Pharmacological Effects and Toxicity Studies (6 papers), Diabetes Treatment and Management (4 papers), Drug-Induced Adverse Reactions (4 papers) and Epilepsy research and treatment (3 papers). The work is most often cited by research in Molecular Medicine (96 citations), Pharmacology (258 citations), Pharmacology (64 citations), Clinical Biochemistry (47 citations) and Endocrinology, Diabetes and Metabolism (98 citations). V. Malerczyk has collaborated with scholars based in Germany, Belgium and South Africa. Frequent co-authors include A. Korn, M. Verho, Karl‐Heinz Lehr, M. Badian, Bernd Rosenkranz, W Waldhäusl, Paul H. Heintzen, Claudia Lange, K. W. Scheel and Péter Hajdú. Their work appears in journals such as Infection, European Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Chemotherapy and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.